Kent Thoelke is the CEO and founder of Paradigm Health, a healthcare tech company with a mission to create equitable access to clinical trials and the best possible care options for any patient anywhere. Mr. Thoelke is a 30-year veteran of the clinical research industry, most recently serving as the Chief Innovation Officer at ICON plc following the acquisition of PRA Health Sciences, where he was Chief Scientific Officer. Throughout his career, he has focused on digital transformation within companies conducting clinical trials, advocating for better use of healthcare data to make drug development more efficient and more equitable for patients. His work spans multiple therapeutic areas and many geographic regions, giving him a truly unique perspective on the needs of patients, physicians, and biotech companies within the clinical research industry.